Connection
Charles Dinarello to alpha-Synuclein
This is a "connection" page, showing publications Charles Dinarello has written about alpha-Synuclein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.426 |
|
|
|
-
Luque M, Matic M, Heras-Garvin A, Amo-Aparicio J, Luk KC, Haindl MT, Khalil M, Skouras DB, Dinarello CA, Stefanova N. Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates a-synuclein-induced progression of parkinsonism. J Neuroinflammation. 2026 Jan 31; 23(1).
Score: 0.232
-
Amo-Aparicio J, Daly J, Højen JF, Dinarello CA. Pharmacologic inhibition of NLRP3 reduces the levels of a-synuclein and protects dopaminergic neurons in a model of Parkinson's disease. J Neuroinflammation. 2023 Jun 22; 20(1):147.
Score: 0.194